Japan’s Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients

Mar 7, 2023 | Press Releases

Language: English | 日本語 (Japanese) Cambridge, MA, March 7, 2023 — Saitama Medical University International Medical Center, one of Japan’s leading hospitals for the treatment of oncology, cardiology, and stroke cases, has joined the TriNetX Network to utilize global...

Japan’s Omi Medical Center, Seikoukai, Becomes the First Healthcare Organization in Western Japan to Sign a Partnership Agreement with TriNetX to Increase Participation in Multi-National Clinical Trials

Feb 27, 2023 | Press Releases

Language: English | 日本語 (Japanese) Cambridge, MA, February 27, 2023 — Omi Medical Center, part of the Seikoukai Social Medical Corporation and one of Japan’s leading institutions in the use of advanced medical technologies, announced it is partnering with TriNetX to...

Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand

Feb 21, 2023 | Press Releases

Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health...

TriNetX Announces the Appointment of Arnaub Chatterjee as Chief Product and Solutions Officer

Feb 14, 2023 | Press Releases

Cambridge, MA, February 14, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Arnaub Chatterjee has joined the company as Chief Product and Solutions Officer....

TriNetX Announces the Appointment of Shields Carstarphen as Chief Commercial Officer

Jan 17, 2023 | Press Releases

Cambridge, MA, January 17, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Shields Carstarphen has joined the company as Chief Commercial Officer. “We are...

South Tees Hospitals NHS Foundation Trust Joins TriNetX to Increase Research Opportunities

Dec 15, 2022 | Press Releases

Cambridge, MA, December 15, 2022 — South Tees Hospitals NHS Foundation Trust, one of the most active research organizations in the northeast of England, has joined the TriNetX network to increase its visibility to commercial partners for additional research...